Results 211 to 220 of about 151,789 (259)

Atrial cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala, Monika Przewłocka‐Kosmala   +1 more
wiley   +1 more source

Effects of artificial light with different spectral compositions on refractive development and matrix metalloproteinase 2 and tissue inhibitor of metalloproteinases 2 expression in the sclerae of juvenile guinea pigs. [PDF]

Eur J Histochem
Yuan J, Li L, Fan Y, Xu X, Huang X, Shi J, Zhang C, Shi L, Wang Y.   +8 more
europepmc   +1 more source

Resistance training modifies of serum levels of matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases in multiple sclerosis women - a randomized controlled trail. [PDF]

BMC Neurosci
Nezhad NN, Parnow A, Khamoushian K, Eslami R, Baker JS.   +4 more
europepmc   +1 more source

RETRACTION: Capn4 is a Marker of Poor Clinical Outcomes and Promotes Nasopharyngeal Carcinoma Metastasis via Nuclear Factor-κB-Induced Matrix Metalloproteinase 2 Expression. [PDF]

Cancer Sci
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Matrix metalloproteinase-2

Annals of the New York Academy of Sciences, 2006
Abstract:  The pathogenesis of abdominal aortic aneurysm (AAAs) involves progressive cycles of proteolysis and inflammation, the product of proteolysis driving subsequent inflammation. Little is yet known about the initiating events. We review the specific literature examining the possibility that MMP‐2 may be the initial catalyst.
Matt, Thompson, Gillian, Cockerill
openaire   +3 more sources

Matrix metalloproteinase‐2 regulates the expression of tissue inhibitor of matrix metalloproteinase‐2

Clinical and Experimental Pharmacology and Physiology, 2010
Summary1. Matrix metalloproteinases (MMP) are associated with the vascular remodelling seen in atherosclerosis and aneurysm. The activation and activity of MMP‐2 are regulated by the intrinsic tissue inhibitor of MMP‐2 (TIMP‐2). The aim of the present study was to examine whether, conversely, MMP‐2 can affect the gene and protein expression of TIMP‐2.2.
Kaoru, Kimura, Xian Wu, Cheng, Kae, Nakamura, Aiko, Inoue, Lina, Hu, Haizhen, Song, Kenji, Okumura, Akihisa, Iguchi, Toyoaki, Murohara, Masafumi, Kuzuya   +9 more
openaire   +2 more sources

Matrix Metalloproteinase-2 in Dentin Matrix Mineralization

Journal of Endodontics, 2001
In the serum-free culture medium of bovine odontoblasts we detected active gelatinolytic metalloproteinases, matrix metalloproteinase (MMP)-2 and MMP-9 (gelatinases A and B). The activity of MMP-2, in particular, appeared suddenly around day 21 in the culture, coinciding with the development of odontoblastic cell processes and the loss of alkaline ...
M, Satoyoshi, A, Kawata, T, Koizumi, K, Inoue, S, Itohara, T, Teranaka, Y, Mikuni-Takagaki   +6 more
openaire   +2 more sources

Matrix Metalloproteinase 2: Involvement in Keratoconus

European Journal of Ophthalmology, 2000
Purpose The activation of matrix metalloproteinase-2 (MMP-2) is postulated to be a crucial pathogenic factor behind progressive and chronic diseases in which basement membranes are disrupted. An ocular example is keratoconus.
V A, Smith, D L, Easty
openaire   +2 more sources

Matrix metalloproteinases 2 and 9, and extracellular matrix in Kaposi's sarcoma

Dermatologic Therapy, 2010
Matrix metalloproteinases (MMPs) are associated with Kaposi's sarcoma (KS) tumorigenesis and may contribute to the mechanism of KS invasive growth. To date, only a few MMPs have been studied in KS lesions, and exactly which MMPs are involved in KS development and progression remains unanswered.
BONGIORNO, Maria Rita, DOUKAKI, Spyridoula, FERRO, Giuseppe, ARICO', Mario   +3 more
openaire   +3 more sources